Tamoxifen in hepatocellular carcinoma
- 1 September 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9130) , 819-820
- https://doi.org/10.1016/s0140-6736(05)60715-5
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trialThe Lancet, 1998
- Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanismJournal of Hepatology, 1995
- Sex hormone receptors in hepatocellular carcinoma: Is there a rationale for hormonal treatment?Journal of Hepatology, 1993